A great beard frames the face, but for most men the hairline is where the real worry starts. October 2026 brought the biggest wave of men’s hair loss treatment news in years: a new oral minoxidil pill with strong Phase 3 data, a hormone-blocking scalp solution heading toward the FDA, and a regenerative topical entering late-stage trials. Here is what is new, what already works, and how men with standards are building a smarter scalp routine.
1. A new oral minoxidil pill just passed Phase 3
Veradermics reported on October 19 that VDPHL01, an extended-release oral minoxidil, met every primary and secondary goal in a Phase 3 trial of 536 men with mild-to-moderate male pattern baldness. After six months, men on the once-daily dose gained an average of 28.6 hairs per square centimeter and men on the twice-daily dose gained 36.4, compared with 6.6 on placebo. Up to 85% of men reported better hair coverage, and the company reported no treatment-related serious side effects and no heart-related events of special interest. The company says it could become the first FDA-approved hair loss pill in nearly 30 years, but it is not approved yet.
Original article: Medscape
2. Why “extended release” matters to dermatologists
Dermatologists have prescribed low-dose oral minoxidil off-label for years, but the usual tablets are immediate release. In Medscape’s report, dermatologist Dr. Pooja Shah explains that an extended-release version may lower peak levels in the blood, which could influence side effects like dizziness or blood pressure changes. Results showed up as early as month two in the trial. The company expects 12-month safety data later this year.
Original article: Veradermics press release
3. Clascoterone: the topical DHT blocker heading to the FDA
Clascoterone 5% solution (proposed name Breezula) blocks the effect of male hormones right at the scalp, where DHT shrinks hair follicles. In 12-month data from a Phase III program of 1,465 men, those who stayed on treatment kept gaining hair, while those switched to placebo after six months lost ground. Safety over a year looked similar to placebo, with no meaningful hormone-related side effects reported. Cosmo Pharmaceuticals plans to file for US approval in early 2027, so it is not on the market today.
Original article: Reuters via Investing.com
4. PP405: trying to wake up “sleeping” follicles
Los Angeles biotech Pelage dosed the first patient in its Phase 2/3 AWAKEN trial on October 14. PP405 is a non-hormonal topical designed to reactivate dormant hair follicle stem cells, and this trial targets men with more advanced hair loss (Norwood IV or V). About 600 men in the US and Canada will be followed for 12 months. Results are still to come, but it is one of the most watched new ideas in the field.
Original article: Pelage Pharmaceuticals
5. What works today: minoxidil and finasteride, with patience
While the new options make headlines, only two drugs are FDA-approved for male pattern hair loss right now: topical minoxidil (over the counter) and finasteride (a prescription pill). Harvard Health notes that both need four to six months of consistent use before you see a change, and they must be continued to keep the results. The American Academy of Dermatology recommends seeing a board-certified dermatologist first, because different types of hair loss need different treatment.
Original article: Harvard Health Publishing
6. Scalp health first, and transplants only after the loss is stable
Northwell Health dermatologists point out that an itchy, flaky or irritated scalp can hold hair growth back, even when the follicles are fine. Seborrheic dermatitis, psoriasis and folliculitis all need their own treatment. They also warn that a hair transplant only moves hair, it does not stop the loss. “You have to stop the loss first,” says dermatologist Dr. Desai, or you may need more procedures later.
Original article: The Well by Northwell
7. Shampoo is scalp care: ketoconazole and the right wash rhythm
GQ’s dermatologist-backed guide to the best shampoo for thinning hair calls shampoo “scalp care, first and foremost” and highlights ketoconazole, an antifungal that may also reduce DHT’s effect at the follicle. Thickening formulas add fullness, but only for the day. Men’s Health adds that men with thick or oily hair should wash three or four times a week, while dry or coarse hair does better with fewer washes.
Original article: GQ
Product Picks: Premium Scalp Care for Thinning Hair
- Augustinus Bader The Scalp Treatment, $93 for 30 ml. A leave-in scalp serum for thinning hair, used two to three times a week on a clean, damp scalp. A refined upgrade for the nightly routine.
- Philip Kingsley Density Thickening Shampoo. From the London trichology house, made for fine and thinning hair to look fuller and stronger after every wash.
This article summarizes published reports and is not medical advice. Talk to a board-certified dermatologist before starting any hair loss treatment.
FAQ: Men’s Hair Loss Treatments in 2026
Is there a new pill for male pattern baldness in 2026?
VDPHL01, an extended-release oral minoxidil, passed a Phase 3 trial in October 2026, but it is not FDA-approved yet. Approval would make it the first new hair loss pill in nearly 30 years.
Is clascoterone (Breezula) available for hair loss?
No. Clascoterone 5% is still investigational for hair loss. Its maker plans to file for US approval in early 2027.
What hair loss treatments are FDA-approved for men today?
Topical minoxidil and oral finasteride. Both take about four to six months to show results and need to be continued to keep them.
Does shampoo stop hair loss?
Shampoo alone does not reverse male pattern baldness, but a healthy scalp supports growth. Dermatologists often point to ketoconazole shampoos, and thickening shampoos make hair look fuller for the day.